Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Unknown 1

Sponsor Class

OTHER 427INDUSTRY 144NIH 22OTHER_GOV 15NETWORK 4UNKNOWN 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 92Breast 59Thoracic 34Head & Neck 18Lymphoid 16CNS 11Other hematologic neoplasm 7Gynecologic 7Dermatologic 5Tumor-Agnostic 4Genitourinary 4Sarcoma 3Other solid neoplasm 3Other neoplasm 2NET 1Myeloid 1Endocrine 1

Conditions

Extrapancreatic Neuroendocrine Tumor 1

Interventions

Thalidomide 1Temozolomide 1Tegafur 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
UNKNOWN × NET × Clear all
NCT03204032 2017-06-29

A Study of Tegafur Combined With Temozolomide Versus Tegafur Combined With Temozolomide and Thalidomide in Subjects With Advanced Extrapancreatic Neuroendocrine Tumor

ChineseAMS

Phase 2 Unknown
60 enrolled
EndocrineGastrointestinalNET

Extrapancreatic Neuroendocrine Tumor

Data powered by HemOnc (CC BY 4.0) Colophon âš¡